Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: Results from the STRONG prospective, observational, multicenter study

American Journal of Cardiovascular Drugs

Volumn 9, Issue 3, 2009, Pages 135-142

  Bahl, Vinay K ^a   Jadhav, Uday M ^b   Thacker, Hemant P ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b BOMBAY HOSPITAL   (India)

^c JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS PERINDOPRIL; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; PERINDOPRIL; UNCLASSIFIED DRUG;

ADULT; AGED; ANKLE EDEMA; ARTICLE; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; COUGHING; DEATH; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; OBSERVATIONAL STUDY; OUTPATIENT; PATIENT COMPLIANCE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL MEDICINE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PERINDOPRIL;

EID: 66849128452     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03256570     Document Type: Article

References (21)

1. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003 Nov 8; 362 (9395): 1527-35
2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 Dec; 42 (6): 1206-52
3. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 Jun; 25 (6): 1105-87
4. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005 Sep 10-16; 366 (9489): 895-906
5. Julius S, Cohn JN, Neutel J, et al. Antihypertensive utility of perindopril in a large, general practice-based clinical trial. J Clin Hypertens (Greenwich) 2004 Jan; 6 (1): 10-7
6. Opie LH, Schall R. Old antihypertensives and new diabetes. J Hypertens 2004 Aug; 22 (8): 1453-8
7. Weir MR. Calcium channel blockers: their pharmacologic and therapeutic role in hypertension. Am J Cardiovasc Drugs 2007; 7 Suppl. 1: 5-15
8. National Institute for Health and Clinical Excellence (NICE), British Hypertension Society (BHS). Hypertension: management of hypertension in adults in primary care. 2006 Jun 28 [online]. Available from URL: http://www.nice.org. uk/ nicemedia/pdf/CG034NICEguideline.pdf [Accessed 2008 Jan 28]
9. Poulter NR, Chang CL,DahlofB,etal.Evaluating the efficacyofthe stepped-care anti-hypertensive strategies used in the Anglo-Scandinavian Cardiac Outcomes Trial BP Lowering Arm (ASCOT) [abstract no. OS11/1]. J Hypertens 2008; 26 Suppl. 1: S10
10. Bertrand M, Sever P. Synergistic effect of perindopril and calcium channel blockers in prevention of cardiac events and death in coronary artery disease patients: analysis from the EUROPA study [abstract no. 3267]. Congress of the European Society of Cardiology (ESC); 2008 Aug 30; Munich
11. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients withstable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003 Sep 6; 362 (9386): 782-8
12. FogariR,Malamani G,ZoppiA,etal. Effectonthe developmentofankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study. Clin Ther 2007 Mar; 29 (3): 413-8
13. Fogari R, Malamani GD, Zoppi A, et al. Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2003 Mar; 17 (3): 207-12
14. Hair PI, Scott LJ, Perry CM. Fixed-dose combination lercanidipine/ enalapril. Drugs 2007; 67 (1): 95-106
15. Miranda RD, MionJrD,Rocha JC, etal.An18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Clin Ther 2008 Sep; 30 (9): 1618-28
16. Jadhav UM, BandukwallaSS. Quinapril in systemic hypertension (QUALISH) study [abstract no. P-103]. J Clin Hypertens (Greenwich) 2006; 8 Suppl. A (5): 50
17. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 2006 Jan; 129 (1 Suppl.): 169S-73S
18. Fogari R, Zoppi A, Mugellini A, et al. Effects of amlodipine, nifedipine GITS, and indomethacin on angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo controlled, double-masked, crossover study. Curr Ther Res 1999; 60 (3): 121-8
19. Sharma A, Bagchi A, Kinagi SB, et al. Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension. Clin Ther 2007 Dec; 29 (12): 2667-76
20. Zannad F, Bernaud CM, Fay R. Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group. J Hypertens 1999 Jan; 17 (1): 137-46
21. Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007 Aug; 120 (8): 713-9